CellMax Life’s Personalized Precision, Non-Invasive Cancer Testing Now Available throughout India through CORE Diagnostics

NEW DELHI, April 13, 2017: CORE Diagnostics, India’s leading clinical laboratory is partnering with Silicon Valley-based CellMax Life to immediately introduce CellMax Life’s genetic cancer risk test and ctDNA-based liquid biopsy throughout India. The two diagnostic advancements hold immense promise to reduce India’s cancer mortality by offering personalized, precision cancer risk assessment and screening. The …